openPR Logo
Press release

Rivaroxaban Market Size by Global Industry Analysis 2018 and Forecast to 2023 by Revenue, Type, Application, Growth and Top Key Players: Bayer, J&J

12-06-2018 07:53 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Report Hive Research

Rivaroxaban Market Size by Global Industry Analysis 2018

Over the next five years Rivaroxaban will register a 9.4% CAGR in terms of revenue, reach US$ 10100 million by 2023, from US$ 5860 million in 2017.

Global “Rivaroxaban Market” peaks the detailed analysis of industry share, growth factors, development trends, size, majors manufacturers and 2023 forecast. The report also analyze innovative business strategies, value added factors and business opportunities. The Rivaroxaban Market report introduces market competition situation among the vendors and company profile, revenue, product & services, latest developments and business strategies.

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.

Download PDF Sample Of this Report @ https://www.reporthive.com/enquiry.php?id=1656050&req_type=smpl

Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.

Rivaroxaban report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

The Key Players Covered in this report:
• Bayer
• J&J and More....

Key Questions Answered in this Report

• What will the market size be in 2023 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?

Segmentation by product type:
• 2.5 mg
• 10 mg
• 15 mg
• 20 mg

Segmentation by application:
• Acute Coronary Syndrome (ACS)
• Venous Thromboembolism (VTE)

Click Here for Purchase Full Report with Full TOC @ https://www.reporthive.com/enquiry.php?id=1656050&req_type=purch

If you have any special requirements, please let us know and we will offer you the report as you want.

Research objectives
• To understand the structure of Rivaroxaban market by identifying its various subsegments.
• Focuses on the key global Rivaroxaban manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Rivaroxaban with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). and More…

Table of Contents
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rivaroxaban Consumption 2013-2023
2.1.2 Rivaroxaban Consumption CAGR by Region
2.2 Rivaroxaban Segment by Type

3 GLOBAL RIVAROXABAN BY PLAYERS
3.1 Global Rivaroxaban Sales Market Share by Players
3.1.1 Global Rivaroxaban Sales by Players (2016-2018)
3.1.2 Global Rivaroxaban Sales Market Share by Players (2016-2018)
3.2 Global Rivaroxaban Revenue Market Share by Players
TOC Continued….!

Tables And Figures
• Figure Picture of Rivaroxaban
• Table Product Specifications of Rivaroxaban
• Figure Rivaroxaban Report Years Considered
• Figure Market Research Methodology
• Figure Global Rivaroxaban Consumption Growth Rate 2013-2023 (M Units) and More….

About Report Hive Research
Report Hive Research delivers strategic market research reports, statistical survey, and Industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME’s, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio & application analysis etc.

500, North Michigan Avenue,
Suite 6014
Chicago, IL - 60611
United States

Contact Us
Mike Ross
Marketing Manager
sales@reporthive.com
https://www.reporthive.com
Phone Number: +1-312 604 7084

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rivaroxaban Market Size by Global Industry Analysis 2018 and Forecast to 2023 by Revenue, Type, Application, Growth and Top Key Players: Bayer, J&J here

News-ID: 1423238 • Views: 187

More Releases from Report Hive Research

2019 Online Grocery Market Key Players Analysis By | Carrefour, Kroger, Tesco, W …
Online Grocery Market Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2028 report has been added to Report Hive Research The Online Grocery Market research report offers you market size, industry growth, share, development trends, product demand, investment plans, business idea and forecasts to 2028. This report highlights exhaustive study of major market along with present and forecast market scenario with useful business decisions. Download PDF Sample of this Report @
Loan Origination Software Market Analysis, Outlook, Size, Share By Leading Playe …
Loan Origination Software Market analysis report provides the details about industry overview, industry chain, market size (sales, revenue, and growth rate), gross margin, major manufacturers, development trends and forecast. The growing Loan Origination Software demand has provided a major boost to the Global Loan Origination Software Market as more software companies are shifting their preferences to Software sector. The market is expected to keep rising at a high CAGR and reach
Digital Transformation Market | Size, Insight, Trends, Outlook By IBM, Oracle, G …
Digital Transformation Market Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2028 report has been added to Report Hive Research. The Digital Transformation Market research report offers you market size, industry growth, share, development trends, product demand, investment plans, business idea and forecasts to 2028. This report highlights exhaustive study of major market along with present and forecast market scenario with useful business decisions. The growth in penetration of IoT-based products
Capsule Hotel Market Size, Share, Trends, Growth and Forecasts Research 2028
Global Capsule Hotel Market report is a complete study of current trends in the Market, business growth drivers, and restraints. It provides Market forecasts for the approaching years 2019-2028. The Capsule Hotel Market 2019 Global industry report covers the latest market statistics, industry growth driving factors, size, share, trends, as well as Forecast till 2028. The Global Capsule Hotel market analysis is provided for the international markets including development trends, competitive

All 5 Releases


More Releases for Rivaroxaban

Rivaroxaban Market Industry Landscape And Acknowledgement with Top Players Janss …
The global rivaroxaban market size is estimated to be valued at US$ 5,653 million in 2017 and is expected to witness a CAGR of 1.5% over the forecast period (2018 – 2026) on account of patent expiry during the forecast period. Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and
Rivaroxaban Market Insights – Stop the Clot
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. Rivaroxaban was discovered by Bayer and is being jointly developed with Janssen Research & Development, LLC. Xarelto is approved for indications such as stroke prevention in non-valvular atrial fibrillation, pulmonary embolism, deep vein
Rivaroxaban
Rivaroxaban is an oral anticoagulant, which was developed by Bayer and sold under the brand name Xarelto. The drug is indicated for the treatment of deep vein thrombosis prophylaxis or pulmonary embolism and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). The drug is marketed by Bayer outside the U.S. and in the U.S., it is marketed by Janssen Pharmaceuticals, Inc. Xarelto is
Rivaroxaban Market - Global Outlook 2026 By TWO KEY Players Janssen Pharmaceutic …
Rivaroxaban is an oral anticoagulant, which was developed by Bayer and sold under the brand name Xarelto. The drug is indicated for the treatment of deep vein thrombosis prophylaxis or pulmonary embolism and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). The drug is marketed by Bayer outside the U.S. and in the U.S., it is marketed by Janssen Pharmaceuticals, Inc. Xarelto is
Rivaroxaban Market to Gain US$ 7890 million by 2022 | Global Key Players – Bay …
A fresh report has been added to the wide database of Business Industry Reports. The research study is titled “Rivaroxaban Market” by Manufacturers, Countries, Type and Application, Forecast to 2022 which provides important data about the production, consumption, revenue and company profiles for key industry participants. Global Rivaroxaban Market Synopsis: According to Market Analyst, Global Rivaroxaban Market is projected to grow at a healthy growth rate from 2019 to 2022. Get Exclusive Sample
Global Rivaroxaban Market to Surpass US$ 7.0 Billion by 2026: CMI
The Global Rivaroxaban Market, by Strength (10 mg, 15 mg, and 20 mg), by Application (Deep Vein Thrombosis Prophylaxis and Pulmonary Embolism), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 5,653 million in 2017 and is projected to exhibit a CAGR of 1.5% over the forecast period